Impact of Nasogastric Tube on Nausea and Vomiting After Jaw Surgery
The Impact of Nasogastric Tube Gastric Decompression on Postoperative Nausea and Vomiting in Orthognathic Surgery
This study is testing if using a nasogastric tube after jaw surgery can help reduce nausea and vomiting in patients during the first day after their operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 92 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Locations | 1 site (Halifax, Nova Scotia) |
| Trial ID | NCT06422793 on ClinicalTrials.gov |
What this trial studies
This study compares the occurrence of postoperative nausea and vomiting (PONV) in patients undergoing orthognathic surgery with and without the use of nasogastric tube gastric decompression. It aims to determine if gastric decompression can reduce the incidence of PONV in the first 24 hours post-surgery. Participants will be randomly assigned to either receive an NG tube for gastric decompression or not, with monitoring for PONV and other influencing factors such as anesthesia type and surgery duration. The study is conducted at Victoria General Hospital in Halifax, Nova Scotia.
Who should consider this trial
Good fit: Ideal candidates are patients over 16 years old undergoing orthognathic surgery for dentofacial deformities at Victoria General Hospital.
Not a fit: Patients under 16, those contraindicated for elective surgery, or those with specific risk factors for PONV may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of postoperative nausea and vomiting in patients undergoing orthognathic surgery.
How similar studies have performed: Other studies have explored the use of nasogastric tubes for PONV management, but this specific approach in orthognathic surgery is less commonly tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 16 at the time of consent undergoing orthognathic surgery for the correction of dentofacial deformities at the Victoria General Hospital during the study period. Orthognathic surgery to include: 1. Patients who receive single-jaw surgery (i.e. BSSO \[Bilateral Sagittal Split Osteotomy\] only, or LeFort only). 2. Patients receiving double-jaw surgery (i.e. BSSO and LeFort). 3. Patients undergoing a functional genioplasty in addition to another osteotomy (i.e. BSSO and/or LeFort). Exclusion Criteria: * Patients will be excluded if they do not meet inclusion criteria or if they have risk factors known to directly impact PONV and/or cause delayed gastric emptying: 1. Patients under the age of 16 at the time of consent. 2. Patients contraindicated to undergo elective surgery, including pregnant patients. 3. Patients undergoing a functional genioplasty procedure only. 4. Patients taking GLP-1 receptor agonists). 5. Patients with known gastroparesis.
Where this trial is running
Halifax, Nova Scotia
- Victoria General Hospital — Halifax, Nova Scotia, Canada (Recruiting)
Study contacts
- Principal investigator: James Brady, DDS/MD — Nsha
- Study coordinator: Katherine A Curry, DDS
- Email: katherinea.curry@nshealth.ca
- Phone: 9024732070
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.